ASML Holding N.V. (LON:0QB8)

CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	200,871	220,593	233,426	178,270	241,265	146,276
Market Cap Growth	-29.35%	-5.50%	30.94%	-26.11%	64.94%	55.99%
Enterprise Value	197,777	220,351	233,444	178,394	240,971	146,472
Last Close Price	518.63	554.95	583.42	439.07	575.12	341.86
PE Ratio	24.97	35.23	34.32	35.74	48.83	45.94
PS Ratio	7.31	9.44	9.76	9.49	15.44	11.68
PB Ratio	13.35	14.44	20.00	22.81	28.33	11.78
P/TBV Ratio	18.86	20.11	33.12	58.89	62.00	19.94
P/FCF Ratio	-	29.32	81.82	27.90	28.88	44.54
P/OCF Ratio	-	23.89	49.42	23.68	26.49	35.28
EV/Sales Ratio	7.05	9.43	9.76	9.50	15.42	11.70
EV/EBITDA Ratio	18.27	27.02	27.74	28.40	41.04	36.12
EV/EBIT Ratio	19.81	29.53	29.75	30.94	43.89	40.35
EV/FCF Ratio	25.07	29.28	81.82	27.92	28.85	44.60
Debt / Equity Ratio	0.21	0.27	0.37	0.53	0.47	0.35
Debt / EBITDA Ratio	0.30	0.51	0.51	0.66	0.67	1.07
Debt / FCF Ratio	0.40	0.56	1.52	0.65	0.48	1.32
Asset Turnover	0.75	0.64	0.72	0.64	0.65	0.56
Inventory Turnover	1.36	1.40	1.67	1.69	1.81	1.71
Quick Ratio	0.71	0.91	0.88	0.80	0.99	1.62
Current Ratio	1.44	1.53	1.50	1.28	1.48	2.41
Return on Equity (ROE)	58.25%	47.43%	70.42%	59.35%	49.01%	26.86%
Return on Assets (ROA)	16.36%	12.74%	14.82%	12.21%	14.21%	10.15%
Return on Capital (ROIC)	34.45%	26.86%	35.39%	28.63%	24.31%	14.62%
Return on Capital Employed (ROCE)	42.70%	31.60%	38.20%	35.50%	36.40%	19.60%
Earnings Yield	4.00%	2.84%	2.91%	2.80%	2.05%	2.18%
FCF Yield	3.93%	3.41%	1.22%	3.58%	3.46%	2.25%
Dividend Yield	0.92%	0.95%	0.91%	1.17%	0.80%	0.72%
Payout Ratio	26.73%	32.40%	29.96%	45.51%	23.26%	30.01%
Buyback Yield / Dilution	0.48%	0.13%	0.98%	3.02%	2.08%	0.59%
Total Shareholder Return	1.40%	1.08%	1.89%	4.19%	2.88%	1.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.